Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net loss $ (4,866) $ (11,634)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Unrealized loss on investments   45
Gain on sale of assets (8,401) (1)
Depreciation and amortization 5,496 5,888
Amortization of operating lease right of use assets 484 280
Change in allowance for doubtful accounts 150 (115)
Non-cash interest income (67) (18)
Deferred tax 784 (1,831)
Share-based compensation 293 1,226
Accretion of debt discount 291 771
Change in fair value of warrant liability   2,163
Loan receivable losses 388 517
Impairment loss and loss on disposal of assets 188 697
Non-cash interest expense 2,037 1,225
Net change in working capital items:    
Trade receivables, net 419 3,654
Inventories 7,004 5,969
Prepaid expenses and other current assets (120) 46
Accounts payable and accrued liabilities 212 (3,500)
Income tax payable 497 407
Deferred revenue (1,015) (1,586)
Net cash provided by operating activities 3,774 4,203
Cash flows from investing activities:    
Purchases of property, plant, and equipment (125) (491)
Proceeds from sale of property, plant and equipment 15,000 3
Repayment of loan receivable, net of advances (2,059) (287)
Net cash provided by (used in) investing activities 12,816 (775)
Cash flows from financing activities:    
Payments on lease liability (1,788) (632)
Repayments on notes payable (10,325)  
Repayments on Revolving Facility (29,073) (32,529)
Debt issuance costs (1,029)  
Proceeds from Revolving Facility 27,316 32,012
Net cash used in financing activities (14,899) (1,149)
Effect of foreign exchange on cash and cash equivalents (2) 1
Net change in cash and cash equivalents and restricted cash 1,689 2,280
Cash and cash equivalents and restricted cash, beginning of year 3,500 6,952
Cash and cash equivalents and restricted cash, end of year 5,189 9,232
Supplemental disclosures of non-cash investing and financing activities:    
Increases to right of use assets related to Pennsylvania Transaction 11,974  
Increase to operating lease liability related to Pennsylvania Transaction 11,880  
Reclassification from accounts payable and accrued liabilities to notes payable related to 2023 New Notes (see Note 10) 8,260  
Warrants issued related to 2023 Notes (equity classified) 5,106  
Noteholder representative fee related to 2023 Refinanced Notes 1,620  
Supplemental disclosure of cash flow information:    
Cash paid for interest $ 1,760 $ 1,044